Previously, Neurogen entered into an agreement to sell the facilities for $6 million, subject to conditions customary for commercial real estate transactions.
Neurogen continues to pursue the monetization of non-core assets, including the scheduled closing in the fourth quarter of 2008 of a previously announced agreement to sell its chemical library for $3 million to a global pharmaceutical company.